Liver Cirrhosis: all 1,668 studies
Page 12 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric VaricesStatus unknownNCT03171805Not applicable
- Low Molecular Weight Heparin for the Prevention of Early TIPS DysfunctionStatus unknownNCT03171727Not applicable
- Effect of Liver Cirrhosis on Semen Parameters and Reproductive HormonesStatus unknownNCT03167749
- Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver CirrhosisCompletedNCT03163745
- To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.WithdrawnNCT03161106Not applicable
- Chronic Hepatitis B Virus Infection in ZambiaCompletedNCT03158818
- Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic PatientsStatus unknownNCT03158701
- Prognostic Biomarkers For Acute Kidney Injury In Liver CirrhosisCompletedNCT03156426
- Oral Fecal Transplant in CirrhosisCompletedNCT03152188Phase 1
- Simvastatin Plus Rifaximin in Decompensated CirrhosisCompletedNCT03150459Phase 2
- Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian AdultsCompletedNCT03149627
- Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in CirrhosisCompletedNCT03144713Not applicable
- Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and NeckTerminatedNCT03139058Not applicable
- Infections in Hospitalized Cirrhotic PatientsCompletedNCT03137719
- Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With CirrhosisStatus unknownNCT03123666Not applicable
- Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene BlueCompletedNCT03120637Phase 4
- Can MRI Evaluate Beta-blocker Response in Portal Hypertension?Status unknownNCT03114813
- Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver CirrhosisStatus unknownNCT03109236Phase 3
- Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control StudyStatus unknownNCT03092401
- Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .Status unknownNCT03084185
- Viatorr CX Case-control Study for Complications of Portal HypertensionCompletedNCT03083925
- Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisStatus unknownNCT03083002
- Role of SWE-change After TIPS in the Prediction of Prognosis After TIPSCompletedNCT03072615
- Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney InjuryCompletedNCT03070353Phase 2/3
- Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C CirrhosisStatus unknownNCT03069339Not applicable
- Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) StudyCompletedNCT03056612
- S-Shearwave Elastography for Assessment of Hepatic FibrosisCompletedNCT03047707Not applicable
- Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based TreatmentStatus unknownNCT03042520
- Oral Gut Liver Axis in CirrhosisCompletedNCT03030820Not applicable
- Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver FibrosisStatus unknownNCT03027921Not applicable
- Methods to Detect Liver FibrosisTerminatedNCT03027700Not applicable
- PEriToneal Catheter Versus Repeated Paracentesis for Ascites in CirrhosisTerminatedNCT03027635Not applicable
- Alcohol Challenge On Liver and Gut Measured by Liver Vein Catheterization. A Pathophysiological Intervention TrialStatus unknownNCT03018990Not applicable
- Fecal Microbiota Transplantation for Decompensated CirrhosisStatus unknownNCT03014505Phase 1/2
- Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior DecompensationWithdrawnNCT03005587
- Anticoagulation for Advanced Cirrhotic Patients After TIPSStatus unknownNCT03005444Not applicable
- Acute Hemodynamic Changes During ParacentesisCompletedNCT02996188
- Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive ProceduresStatus unknownNCT02987712Not applicable
- Peritoneal Dialysis Catheters for the Treatment of Refractory AscitesCompletedNCT02975726Not applicable
- Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing ImagingCompletedNCT02967198Not applicable
- The Effects of the Anhepatic Phase Extended by Temporary Portocaval Shunt on Anesthetic Sensitivity and Cognitive FunctionCompletedNCT02965131Not applicable
- Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center StudyCompletedNCT02958592
- Effects on Liver Cirrhotic Patients' by a Nurse-led ClinicCompletedNCT02957253Not applicable
- Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver TransplantationCompletedNCT02949505Not applicable
- Mindfulness and Support Group to Improve Patient and Caregiver Burden in CirrhosisCompletedNCT02944643Not applicable
- Stem Cell Transplantation in Cirrhotic PatientsStatus unknownNCT02943889Phase 1/2
- On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With CirrhosisStatus unknownNCT02937935Not applicable
- Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-respondersStatus unknownNCT02937012Phase 3
- Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap SyndromeStatus unknownNCT02936596Not applicable
- Methods for Nutritional Assessment in CirrhosisStatus unknownNCT02926261
- Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of CirrhoticsStatus unknownNCT02923336Not applicable
- FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)CompletedNCT02922751
- Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China HospitalCompletedNCT02917408
- Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisStatus unknownNCT02916290Phase 3
- Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in CirrhosisCompletedNCT02907749Phase 4
- FDGal PET/CT to Detect Hepatocellular CarcinomaWithdrawnNCT02899325
- French HIV-HBV CohortStatus unknownNCT02889094
- Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.WithdrawnNCT02868164Not applicable
- Regression of Liver Fibrosis After Daclatasvir and Asunaprevir TreatmentStatus unknownNCT02865369
- Trial of Faecal Microbiota Transplantation in CirrhosisCompletedNCT02862249Phase 3
- Microparticles in Cirrhosis and Portal HypertensionCompletedNCT02859610Not applicable
- Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC SurveillanceStatus unknownNCT02854241Not applicable
- TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPVStatus unknownNCT02853526Phase 3
- Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis PatientsActive, not recruitingNCT02849132Phase 4
- Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune DysfunctionWithdrawnNCT02837939Phase 2/3
- Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver DiseaseStatus unknownNCT02837302Phase 4
- A Follow-up Evaluation Study of PRI-724-1101CompletedNCT02828254
- Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.WithdrawnNCT02824354Phase 3
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic AcidStatus unknownNCT02823366Phase 3
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedNCT02823353Phase 3
- SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic EncephalopathyTerminatedNCT02811887Not applicable
- The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)WithdrawnNCT02809248Not applicable
- Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 StudyCompletedNCT02806011
- Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic PatientsTerminatedNCT02798939
- Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?CompletedNCT02787772Not applicable
- Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated CirrhosisStatus unknownNCT02786017Phase 1/2
- Hepatocellular Carcinoma in HIV-infected PatientsCompletedNCT02785835
- The Treatment of Hepatocirrhosis and Portal HypertensionCompletedNCT02778425Not applicable
- Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.Status unknownNCT02767206
- The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of MulticenterStatus unknownNCT02752529Not applicable
- Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis CCompletedNCT02744105Not applicable
- Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced CirrhosisWithdrawnNCT02739581Not applicable
- Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated CirrhosisStatus unknownNCT02732405Phase 3
- Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic CirrhosisStatus unknownNCT02710227
- Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV HepatitisStatus unknownNCT02705742Phase 1/2
- Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1CompletedNCT02705534Phase 3
- Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic PatientsCompletedNCT02702739Phase 4
- The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal BleedingStatus unknownNCT02695732Phase 4
- Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected PatientsCompletedNCT02693847
- The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).Status unknownNCT02692430
- Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver FibrosisCompletedNCT02682108Not applicable
- Serelaxin To Lower Portal PressureCompletedNCT02669875Phase 2
- Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic CirrhosisStatus unknownNCT02652351Phase 1
- Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With CirrhosisStatus unknownNCT02643212Phase 3
- Methocarbamol in Treatment of Muscle Cramps in Cirrhotic PatientsStatus unknownNCT02642874Phase 3
- Cyclobenzaprine in Muscle Cramps With Liver CirrhosisStatus unknownNCT02642861Phase 3
- Gabapentin in Treatment of Muscle Cramps in Patients With Liver CirrhosisStatus unknownNCT02642484Phase 3
- To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated CirrhosisCompletedNCT02642003Phase 3
- The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric VaricesStatus unknownNCT02638415Phase 4
- Fecal Transplant in Recurrent Hepatic EncephalopathyCompletedNCT02636647Phase 1